News: Owners Developers & Managers

McFarland and Twombly of Avison Young arrange 7,050 s/f lease at 33 Arch Street to Juniper Pharmaceuticals

Boston, MA According to Avison Young, Juniper Pharmaceuticals has signed a 7,050 s/f lease at 33 Arch St. Avison Young’s Karyn McFarland and Matt Twombly, a principal and vice president, respectively, in the firm’s Boston office, represented Juniper Pharmaceuticals in the transaction. CBRE represented the landlord, TIAA-CREF. Juniper Pharmaceuticals will move from its current location at 4 Liberty Sq.

“Juniper Pharmaceuticals has experienced tremendous growth, doubling in size over the past two years,” said McFarland. “The new space at 33 Arch St. will help the firm as it continues to expand.”

The 33 Arch St. site is located in the between Downtown Crossing and the Financial District. The property provides views of the Charles River and Boston Common, as well as convenient access to four branches of the MBTA and South Station.

Juniper Pharmaceuticals, Inc. is focused on developing therapeutics that address unmet medical needs in women’s health. Juniper has a commercial product, CRINONE 8% (progesterone gel), which is marketed by Allergan, Inc. in the U.S. and by Merck KGaA, Darmstadt, Germany, in over 90 countries worldwide. The company is advancing a pipeline of proprietary drug candidates leveraging novel delivery technologies. Juniper Pharmaceuticals is a trademark of Juniper Pharmaceuticals, Inc., in the U.S. and EU. CRINONE is a registered trademark of Allergan, Inc. in the U.S. and of Merck KGaA, Darmstadt, Germany, outside the U.S

Avison Young is one of the world’s fastest-growing commercial real estate services firms. Headquartered in Toronto, Canada, Avison Young is a collaborative, global firm owned and operated by its principals. Founded in 1978, the company comprises 2,000 real estate professionals in 73 offices, providing value-added, client-centric investment sales, leasing, advisory, management, financing and mortgage placement services to owners and occupiers of office, retail, industrial and multi-family properties.

READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
Revitalized Town Centers:  Retail??? - by Carol Todreas

Revitalized Town Centers: Retail??? - by Carol Todreas

It is now widely accepted that customers want to shop in person at physical stores. Brands know that they do better business in a physical store than just on line so they want to open stores. Demand for retail space by digital merchants, local entrepreneurs, and newly developed national chains
IREM president’s message:  Our new reality - Staying ahead of supply chain delays - by Yoany Vargas

IREM president’s message: Our new reality - Staying ahead of supply chain delays - by Yoany Vargas

Supply chain delays are slowing construction, ratcheting up operating costs, and extending turnover timelines across Greater Boston, directly reducing revenue and increasing the workload for multifamily and

Florida ruling raises bar for condo terminations and buyouts - by Michael Karsch

Florida ruling raises bar for condo terminations and buyouts - by Michael Karsch

On October 14, 2025, in a landmark decision with significant implications for the Florida real estate market, the Supreme Court of Florida formally denied Two Roads Development’s (TRD Biscayne LLC) petition for review in its long-running case against unit owners of Biscayne 21,
Retail infill strategy to activate Pawtucket’s Conant Thread District - by Gaetan Kashala

Retail infill strategy to activate Pawtucket’s Conant Thread District - by Gaetan Kashala

Until recently, the Conant Thread District consisted of approximately 150 acres of underutilized industrial land spanning Pawtucket and Central Falls. Today, the area is one of the most significant